Trial of Neoadjuvant Ipilimumab Followed by Melphalan Via Isolated Limb Infusion for Patients With Unresectable In-transit Extremity Melanoma
Clinical trial NCT02115243 · COMPLETED
Trial details
- NCT number
- NCT02115243
- Sponsor
- Duke University
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2015-12-07
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.